CONTACT US
Home > Browse by topic > Pharmaceuticals

Pharmaceuticals Expert Witnesses

Pharmaceutical litigation spans patent disputes over drug formulations and manufacturing processes, product liability claims concerning safety and labeling, securities and derivatives claims tied to clinical trial results or regulatory approvals, and trade secret disputes involving proprietary formulation or manufacturing know-how. Because drug development moves through years of preclinical research, clinical trials, and FDA review before commercialization, disputes often hinge on what was known, disclosed, or represented at a specific point in that process. Rapid development timelines, such as those seen during the push to bring COVID-19 therapeutics to market, have intensified scrutiny of disclosures made to investors and regulators alike. Attorneys need technical and scientific expertise to determine whether a company's conduct at each stage met applicable scientific, regulatory, and disclosure standards.

A pharmaceutical expert can explain formulation chemistry, drug metabolism, and manufacturing processes to establish whether a product performed and was made as claimed, supporting or rebutting patent infringement and product liability positions. In securities-related disputes, the expert can assess whether statements about clinical trial results, safety data, or regulatory prospects were reasonable given the scientific information available at the time, informing both liability and damages analysis. Where FDA compliance is at issue, the expert situates a company's manufacturing and quality practices against applicable regulatory standards to support compliance or rebuttal arguments. This scientific grounding gives attorneys the specificity needed to connect technical facts to causation and damages theories.

Selecting a pharmaceutical expert whose scientific background aligns precisely with the drug, process, or regulatory issue in dispute is essential to building a credible case. Round Table Group's pharmaceutical network includes scholars and industry veterans who have worked at companies such as GlaxoSmithKline, Abbott Laboratories, and Pfizer, spanning medicinal chemistry, pharmacology, clinical drug development, and regulatory affairs. Having completed more than 75,000 expert searches for litigators, we understand how to match a case's specific formulation, clinical, or regulatory question to an expert with directly relevant experience. Let us help you make sure you have the right expert on your pharmaceutical case by calling us at (202) 908-4500.

Kinds of Cases We Work On

Round Table Group helps our clients find a wide variety of Pharmaceuticals expert witnesses for cases like:

01

Hatch-Waxman patent settlement compliance dispute

A branded pharmaceutical manufacturer sued a generic competitor for launching its generic version several months ahead of the entry date specified in their patent litigation settlement agreement, seeking damages for the resulting erosion of the branded product's market share during the disputed window. A pharmaceutical regulatory and patent settlement practices expert reviewed the generic manufacturer's FDA approval timeline and the settlement agreement's specific entry-date triggering provisions, which were tied to a defined set of triggering events involving other generic entrants. The expert found none of the settlement's specified triggering events had actually occurred before the generic company launched, meaning the early launch breached the agreement's plain terms rather than falling within any permitted early-entry exception. That finding was central to the court's ruling in the branded manufacturer's favor, resulting in a damages award reflecting the lost exclusivity period.
02

PBM rebate and formulary compliance dispute

A pharmaceutical manufacturer sued a large pharmacy benefit manager, alleging the PBM had failed to deliver the preferred formulary tier placement contractually guaranteed in exchange for the manufacturer's rebate payments, resulting in lower-than-expected prescription volume across the PBM's client base. A pharmaceutical pricing and PBM contracting expert reviewed the PBM's formulary files and claims data across the disputed period against the specific tier placement commitments in the rebate agreement. The expert found the manufacturer's product had, in fact, been placed on a less favorable tier than contracted for a meaningful share of the PBM's client plans during the disputed period, a discrepancy the PBM's own internal formulary change logs confirmed. That finding supported the manufacturer's breach of contract claim and was central to the settlement, which included a rebate credit reflecting the lost volume.
03

Wholesaler chargeback dispute

A pharmaceutical manufacturer sued a national wholesaler after an audit revealed the wholesaler had submitted chargeback claims for sales to customers not actually eligible for the manufacturer's contract pricing, resulting in tens of millions of dollars in improperly reimbursed chargebacks over several years. A pharmaceutical distribution and trade practices expert reviewed a sample of the disputed chargeback claims against the underlying contract pricing eligibility rosters and the wholesaler's own transaction records. The expert found that a meaningful share of the sampled claims had been submitted for sales to accounts that had already been removed from the eligible customer roster the manufacturer had provided months earlier. That finding, extrapolated across the full claims population, anchored the damages figure used in the settlement, which included repayment of the improperly claimed chargebacks.
04

Medicaid best price and rebate calculation dispute

A pharmaceutical manufacturer sued a rebate aggregator it had contracted with to administer a value-based rebate arrangement, alleging the aggregator's program design had inadvertently triggered a Medicaid "best price" calculation that increased the manufacturer's federal rebate liability by tens of millions of dollars, contrary to the aggregator's representations about the program's structure. A pharmaceutical government pricing expert reviewed the rebate program's terms against Medicaid best price regulations and the specific structuring safe harbors the aggregator had represented the program was designed to satisfy. The expert found the program's rebate calculation methodology did not, in fact, meet the specific bundling exclusion the aggregator had represented would keep it outside best price calculations. That finding supported the manufacturer's negligent misrepresentation claim against the aggregator and was significant in the settlement covering a portion of the increased rebate liability.
05

340B program diversion dispute

A pharmaceutical manufacturer sued a hospital's contract pharmacy network, alleging a pattern of 340B-discounted drugs had been diverted to patients who didn't qualify as the covered entity's patients under the program's eligibility requirements, resulting in improper duplicate discounting on drugs also subject to Medicaid rebates. A pharmaceutical compliance expert specializing in the 340B program reviewed a sample of the contract pharmacy's dispensing records against the covered entity's patient eligibility documentation and standard 340B program compliance practices. The expert found that a meaningful share of the sampled dispensations lacked documentation establishing the patient met the covered entity's own eligibility criteria for 340B-priced drugs. That finding supported the manufacturer's claim and contributed to a settlement that included repayment for the improperly discounted units and revised eligibility verification procedures.
06

Drug shortage allocation dispute

During a nationwide shortage of a critical injectable medication, a hospital group purchasing organization sued the manufacturer, alleging its allocation methodology during the shortage had disproportionately favored certain distribution channels in violation of the fair allocation commitments in their supply agreement. A pharmaceutical supply chain expert reviewed the manufacturer's allocation records and methodology against the specific fair allocation provisions in the supply agreement and standard industry practice for allocating scarce product during shortages. The expert found the manufacturer's allocation formula had, in fact, applied a historical purchase volume baseline that predated a documented shift in the GPO's member hospital needs, resulting in an allocation shortfall relative to the GPO's actual clinical demand. That finding supported the GPO's breach of contract claim and was significant in the settlement, which included a supplemental allocation once production normalized.
07

Active pharmaceutical ingredient supplier quality dispute

A generic drug manufacturer sued its API supplier after a series of finished-dose batches failed dissolution testing, traced to inconsistent particle size distribution in the supplied API, resulting in a costly product recall. A pharmaceutical manufacturing and quality expert reviewed the API supplier's certificate of analysis data and particle size testing records against the specification incorporated into their supply agreement. The expert found several of the implicated API lots had particle size distribution results near the edge of specification that the supplier had released without the additional testing its own quality procedures called for at that proximity to the specification limit. That finding supported the manufacturer's breach of contract claim against the supplier and was central to the settlement covering the recall costs.
08

Orphan drug exclusivity dispute

Two pharmaceutical manufacturers with competing therapies for related rare diseases became embroiled in litigation when one manufacturer's product received orphan drug exclusivity that the other argued improperly blocked approval of its own therapy for an overlapping patient population, in breach of an earlier settlement agreement defining each company's respective disease scope. A pharmaceutical regulatory expert reviewed the clinical and regulatory basis for the exclusivity determination against the specific disease population definitions the parties' earlier settlement agreement had negotiated. The expert found the exclusivity holder's approved indication, properly construed under the settlement agreement's disease definitions, did not actually extend to the specific patient subpopulation the other manufacturer's product targeted. That finding supported the second manufacturer's claim that the blocking effect exceeded what the settlement agreement contemplated and was significant in the negotiated resolution clarifying each party's respective market.
09

Specialty pharmacy limited distribution network dispute

A pharmaceutical manufacturer terminated a specialty pharmacy's participation in its limited distribution network for a high-cost specialty drug, and the pharmacy sued for breach of contract, alleging the manufacturer's stated performance justification didn't match the specific performance metrics defined in their network agreement. A pharmaceutical distribution and specialty pharmacy operations expert reviewed the pharmacy's patient adherence, fill-time, and reimbursement support metrics against the specific benchmarks and thresholds defined in the network participation agreement. The expert found the pharmacy's performance across all of the agreement's own defined metrics met or exceeded the required thresholds during the disputed period. That finding supported the pharmacy's breach of contract claim and contributed to a settlement reinstating its network participation.
10

Government pricing compliance indemnification dispute

A pharmaceutical manufacturer sued its prime vendor distributor for breaching Federal Supply Schedule pricing compliance terms in their distribution agreement, after a government audit revealed the distributor had marked up pricing to certain federal facilities above what the manufacturer's FSS contract ceiling allowed, exposing the manufacturer to potential government liability. A pharmaceutical government pricing expert reviewed the distributor's invoicing records for federal facility sales against the FSS ceiling price schedule incorporated into their distribution agreement. The expert found a pattern of invoices to federal facilities priced above the FSS ceiling for a sustained period, a compliance failure attributable to the distributor's pricing system not having been updated after a scheduled FSS price adjustment. That finding supported the manufacturer's indemnification claim and was central to the settlement, which required the distributor to fund the manufacturer's remediation costs.

Here are a few of our favorite Pharmaceuticals Expert Witnesses:

Missouri Outsourcing Pharmaceuticals Expert #53770

This sample expert has 25 years of experience, and specializes in the field of outsourcing pharmaceuticals with specific knowledge in the areas of contract development, contract manufacturing and contract research. Testified on contract drug development, CRO, CMO, CDMO, CRMO and CRAM

 

North Carolina Pharmaceutical Development Expert #4231

I have 44 years of experience, and specialize in the field of pharmaceutics with specific knowledge in the areas of pharmaceutical development, tech licensing, competitive intelligence, and primary and secondary market research. I have published on such topics as drug disposition, pharmacokinetics and drug metabolism. I was a Senior Research Scientist at Big Pharma for over 25 years and worked in the labs of Nobel laureates Gertrude Elion and George Hitchings.

 

Massachusetts Pharmaceutical Science Expert #4350

I have 17 years of experience, and specialize in the field of pharmaceutical science with specific knowledge in the areas of drug delivery, nanomedicine and biomaterials. I have published on such topics as drug and gene delivery, nanotechnology and biomaterials. I have testified on drug formulations, nanotechnology and cancer therapy. I have supervised and trained over 80 students in their research ranging from BS to PhD and post doctorates.

 

Ohio Medicine, Pharmaceuticals, Drug Expert #10587

I have 25 years of experience, and specialize in the field of psychiatry with specific knowledge in the areas of psychopharmacology, drug development and patent litigation. I have published on such topics as attention deficit hyperactivity disorder, stimulants and alpha adrenergic agonists. I have testified 10 times on topics such as method of use patents, drug-drug interaction and pharmaceutical product liability. I am an internationally known expert in psycho stimulants as it applies to attention deficit hyperactivity disorder treatment. I have used this knowledge to assist pharmaceutical companies develop new products and formulations, reposition older products and protect patents.

 

Nevada Health Care, Pharmaceuticals Expert #10978

I have 25 years of experience, and specialize in the field of medicine with specific knowledge in the areas of pain management, interventional pain management and anesthesiology. I have published on such topics as electro analgesia, the use of electronic signal treatment in the treatment of inflammation and the combined electrochemical block. I have testified on fires in the operating room, utilization of lumbar decompression, and neurodiagnostic testing. I have developed a safe and effective treatment for neuropathies and inflammatory pain problems.

 

Your Case Deserves The Best Pharmaceuticals Expert Witnesses

Registered icon

The right expert witnesses and consulting experts can make your case. That’s why we have spent so many hours over the past quarter century making sure our clients have just the right expert team — whether one expert or many, early-stage advice or expert reports and testimony. Across over 50,000 expert search assignments, we have honed a unique, customized approach to identifying, analyzing and connecting with expert talent so you can focus on winning your case.

LET US HELP YOU

Alabama Internal Medicine Expert #11825

I have 20 years of experience, and specialize in the field of internal medicine with specific knowledge in the areas of pharmaceuticals, vaccines and clinical research. I have published on such topics as vaccine, adverse effects and hepatitis. I have testified 90 times on topics such as drug adverse effects, standard of care and infections. I am able to merge clinical practice, research and legal support.

 

Illinois Gastroenterology Expert #13113

I have 30 years of experience, and specialize in the field of gastroenterology with specific knowledge in the areas of acid peptic disease, gastroesophageal reflux disease (GERD) and proton pump inhibitors. I have published on such topics as proton pump inhibitors, ulcer disease and GERD. I have testified on PPIs, and bisphosphonates.

 

Michigan Medicinal Chemistry Expert #13958

I have 25 years of experience, and specialize in the field of medicinal chemistry with specific knowledge in the areas of drug design, peptides and structure activity relationships. I have published on such topics as opioid agonists and antagonists, thrombin inhibitors and anticoagulants and protein structure modeling. I have testified on angiotensin converting enzyme inhibitors, stereochemistry and structure-activity relationships.

 

New Jersey Pharmaceuticals, Advertising Expert #14741

I have 20 years of experience, and specialize in the field of marketing with specific knowledge in the areas of pharmaceuticals, drugs and advertising. I have published on such topics as medicine, drugs and healthcare.

 

Michigan Pharmaceutical Products Expert #17482

I have 30 years of experience, and specialize in the field of pharmaceutical and cosmetic products with specific knowledge in the areas of emulsions and surface chemistry, formulation design and topicals and transdermals. I have published on such topics as surface chemistry, liquid and semi-solid formulation design, topical and parenteral products and cosmetic and personal care formulations. I have testified 20 times on topics such as surface chemistry and surfactants, topical, transdermal and parenteral formulations and cosmetic and personal care products.

 

North Carolina Clinical Drug Development Expert #18994

I have 15 years of experience, and specialize in the field of clinical drug development with specific knowledge in the areas of metabolic diseases, arthritis, immunology and Alzheimer’s. I have published on such topics as immunology, gastrointestinal diseases and arthritis.

 

Florida Pharmaceutical Research and Development Expert #22844

I have 50 years of experience, and specialize in the field of pharmaceutical research and development with specific knowledge in the areas of dosage form design, manufacturing and evaluations. I have about 150 publications and have a dozen or more U.S. patents. I have testified 30 times on topics such as pharmaceutical research and development.

 

Kentucky Pharmaceuticals, Prodrugs Expert #24092

I have 12 years of experience and specialize in the field of organic chemistry, with specific knowledge of organic synthesis, pharmaceuticals and polymers. I have published on such topics as organic synthesis, pharmaceuticals and drug design.

 

Pennsylvania Drugs, Pharmaceuticals Expert #24724

I have 30 years of experience, and specialize in the field of healthcare communication with specific knowledge in the areas of marketing, education and advocacy.

 

Colorado Organic Chemistry Expert #20165

I have 33 years of experience, and specialize in the field of organic and pharmaceutical chemistry with specific knowledge in the areas of anti-cancer drugs, heterocyclic compounds and peptides and amino acids. I have published on such topics as natural products synthesis, synthetic methodology and antibiotics and anti-cancer drugs. I have testified on drug formulation, anti-viral drugs, anti-depressants, microcline antibiotics, and anti-cancer drugs, and quinolone antibiotics, heterocyclic. I am experience in drug formulation, drug manufacturing, process chemistry and medicinal chemistry.

 

Pharmaceuticals, Genetics, Risk Expert #23259

I have 20 years of experience, and specialize in the field of pharmacology with specific knowledge in the areas of pharmacogenetics, toxicology and drug side effects. I have published on such topics as pharmacogenetics, chemical carcinogenesis and protein structural biochemistry. I have testified on pharmaceutical patent litigation. I currently act as chair of the department of pharmacology and toxicology at a university, with administrative responsibility for a complement of over 60 internationally recognized scientific faculty members, in one of the oldest and largest pharmacology departments. I have also had senior managerial experience in the United States biotechnology sector.

 

Alabama Chemical Crystallography Expert #26392

I have 26 years of experience, and specialize in the field of chemical crystallography with specific knowledge in the areas of crystallization, polymorphism and solid state chemistry. I have published on such topics as crystal structures, ionic liquids and pharmaceutical salts. I have testified 7 times on topics such as crystal size of pharmaceuticals, polymorphism and formulation chemistry.

 

Texas Medicinal Chemistry Expert #26947

I have 30 years of experience and specialize in the field of organic chemistry, with specific knowledge of medicinal chemistry, fluorescent dyes and asymmetric catalysis. I have published on such topics as peptidomimetics, medicinal chemistry and synthetic dyes. I have testified on pharmaceutical processes, pharmaceutical composition of matter and organic synthesis.

 

North Carolina Pharmaceuticals, Nursing, Health Expert #27305

I have 35 years of experience and specialize in the field of registered nursing, with specific knowledge of post anesthesia. I have published on such topics as community service, oxygen saturation and advanced cardiac life support.

 

New York Pharmaceuticals Expert #28764

I have 30 years of experience, and specialize in the field of pharmaceuticals with specific knowledge in the areas of drug development, discovery and commercialization. I have testified on litigation, settlements and patents.

 

New Jersey Clinical Drug Development Expert #29037

I have 10 years of experience and specialize in the field of clinical drug development, with specific knowledge of lipid metabolism, atherosclerosis and diabetes. I have published on such topics as clinical trials of novel lipid-lowering agents and the utility of biomarkers of atherosclerosis. I have testified on pharmaceutical clinical development programs.

 

Ohio Drug Development Expert #31701

I have 30 years of experience and specialize in the field of drug development, with specific knowledge of process chemistry, project management and good manufacturing practices (GMP) regulations. I have published on such topics as antibacterials, antifungals and kinases. I have testified on infringement.

 

Drug Toxicity Expert #34258

I have 32 years of experience and specialize in the field of toxicology and pharmaceuticals with specific knowledge in the areas of lung toxicity, anticancer drugs and antioxidants. I have published on such topics as free radical toxicity, anticancer drug toxicity and cardiac toxicity. I have testified on smoke and fog machine toxicity, drug toxicity and lung toxicity.

 

North Carolina Organic Chemistry Expert #41315

I have 30 years of experience, and specialize in the field of organic chemistry with specific knowledge in the areas of synthetic organic chemistry, heterocyclic chemistry and pharmaceuticals. I have published on such topics as the synthesis of heterocycles, pharmaceutically interesting heterocycles and nucleic acids chemistry.

 

Connecticut Biotechnology, Pharmaceuticals Expert #43174

I have 48 years of experience, and specialize in the field of patent law with specific knowledge in the areas of chemical, pharmaceutical and biotechnology. I have published on such topics as patents. I have testified on patent office procedures, trade secrets and inequitable conduct. Successfully argued for the reversal of a doctrine of “willfulness” which imposed punitive damages for the failure to obtain an opinion of counsel.

 

Utah Health Care, Pharmaceuticals Expert #46903

I have 27 years of experience, and specialize in the field of anesthesiology with specific knowledge in the areas of pain medicine, hospice and palliative care. I have published on such topics as pain and aging, opioid therapy, neurobiology of pain and palliative care. I have testified 10 times on topics such as pain care, palliative care and standards of care in use of opioid analgesics. I have worked as one of the medical directors for the 2002 Olympics.

 

Florida Transdermal, Formulation Expert #38775

I have 26 years of experience, and specialize in the field of transdermals with specific knowledge in the areas of formulation, intellectual property and product development. I have published on such topics as adhesives for transdermals, estrogen replacement therapy and the science of transdermal development. I have testified on intellectual property, inventiveness and infringement. I have 13 U.S. patents and several applications for others. Developed six current commercial transdermal products. Published articles as well as chapters on the subject of transdermals.

 

Arizona Pharmaceutical Sciences Expert #40113

I have 39 years of experience, and specialize in the field of pharmaceutical sciences with specific knowledge in the areas of pharmacokinetics, pharmaceutics and biopharmaceutics. I have published on such topics as drug disposition in animals and humans, drug-drug interactions and drug absorption. I have testified 25 times on topics such as absorption, drug dissolution, in-vitro in-vivo correlation (IVIVC), metabolism, drug-drug interactions and dosage form assessment. I have advised over 20 graduate students who are primarily in the pharmaceutical industry. I have offered a well-received one-week course in pharmacokinetics to industrial pharmaceutical scientists.

 

Virginia Gastroenterology Expert #42504

I have 25 years of experience, and specialize in the field of gastroenterology with specific knowledge in the areas of ulcerative colitis, Crohn’s disease and irritable bowel syndrome. I have published on such topics as diarrhea, constipation and irritable bowel syndrome. I have testified on bile duct perforation and Crohn’s disease. I have been uniquely positioned at the level of translational medicine between drug discovery, drug development, and clinical medicine. I have served not only as a professor of medicine and researcher, but also experienced biotech and pharmaceutical executive, bridging these two worlds.

 

Florida Pharmaceuticals, Chemicals, Acid Expert #47210

I specialize in the field of chemistry with specific knowledge in the areas of organic chemistry, synthesis and hazardous substances. I have published on such topics as organic synthesis, organic methods and acid and base chemistry. I have testified on explosive devices, strong acids and bases and hazardous material. I have accepted an international award as a visiting professor.

 

California Chemicals, Pharmaceuticals Expert #47965

I have 30 years of experience, and specialize in the field of organic chemistry with specific knowledge in the areas of drug synthesis, agrochemicals. I have published on such topics as photochemistry, plant hormones and nucleic acids. I have testified on microarray fabrication. I have published in 11 different American chemical society journals.

 

Washington D.C. Development, Pharmaceuticals Expert #48262

I have 22 years of experience, and specialize in the field of federal drug administration regulatory affairs with specific knowledge in the areas of biologics, bio similar and combination products. I have published on such topics as healthcare legislation, drug development and compliance.

 

Utah Antiviral Chemotherapy Expert #50228

I have 32 years of experience, and specialize in the field of antiviral chemotherapy with specific knowledge in the areas of pre-clinical drug development in cell culture and animal models, working with pharmaceutical companies and evaluating scientific data pertaining to this field. I have published on such topics as anti-herpes compounds related to acyclovir and ganciclovir, the anti-influenza compounds related to oseltamivir and zanamivair and antiviral compounds related to ribavirin. I have testified on anti-herpes approved Federal Drug Administration drug. I have professional experience in industry, academia, and working for the government. My field of expertise is applied, i.e., to…

 

Utah Medicinal Chemistry Expert #50632

I have 50 years of experience, and specialize in the field of medicinal chemistry with specific knowledge in the areas of nucleosides, nucleic acids and antifolates. I have published on such topics as anticancer antifolates, anticancer nucleosides and antiviral nucleic acids. I have testified on antifolates, nucleosides and nucleic acids.

 

New York Drug Development Expert #51341

I have 20 years of experience and specialize in the field of pharmaceutical science with specific knowledge in the areas of formulation, controlled and modified release, and solubility and stability. I have published on such topics as stability of amorphous dosage forms, pulsatile microdialysis and transdermal drug delivery. I have testified on solid solutions in dosage forms and the effects of water in the formulation process.

 

Maryland Pharmaceuticals, Tablets Expert #52945

I have 12 years of experience, and specialize in the field of pharmaceuticals with specific knowledge in the areas of tablets and capsules, controlled release and FDA regulations. I have published on such topics as granulation’s, controlled release polymers for tablets and near-infrared spectroscopy. I have been an invited speaker at national scientific meetings and have received several awards for some of my innovative scientific research.

 

Put Our Pharmaceuticals Expert Network to Work for You

Registered icon

Our huge network of experts – eminent university professors and practitioners who have achieved renown as thought leaders in their fields – combined with unparalleled research capabilities puts the experts you need at your disposal when and where you need them.

If you’re a litigator or general counsel, we want to put this network to work for you and your clients. Let us know how we can help by calling us at (202) 908-4500 or filling out the form on this page. We’re so confident you’ll love what we do that unless you retain an expert we present there’s no charge!

LET US HELP YOU

Questions Attorneys Ask About Pharmaceuticals Expert Witnesses:

Attorneys typically retain a pharmaceutical expert once a case turns on formulation chemistry, manufacturing process, clinical trial data, or regulatory compliance questions, which arise in patent, product liability, securities, and trade secret disputes involving drug products. An expert can also help counsel evaluate a case's scientific merits before committing to a particular theory.
Search again

GET STARTED FINDING THE RIGHT EXPERT WITNESS

Spend your time working with your experts, not searching for them! We're here to de-stress the process of having a great expert witness team so that it’s easy to have the right experts every time. We'll conduct a quick but thorough search and deliver a roster of top candidates for you to review. There's no charge for the custom search — you pay only the hourly rate if you retain one of our experts.

  • This field is for validation purposes and should be left unchanged.

Or call 202-908-4500 or email us.

Pharmaceuticals Workshops

A few of the courses and workshops led by our Pharmaceuticals experts:

  • Introduction to Biopharmaceuticals & Biosimilars

Related topics

Aging
Biomaterials
Biotech Pharma
Business Development
Chemicals
Chemistry
Compliance
Drug Delivery
Drug Design
Drug Development
Drug Discovery
Gene Therapy
Hypertension
Infectious Disease
Manufacturing
Materials Science
Organic Chemistry
Patent
Pathology
Pharmacy
Policy
Process Development
Quality
Tissue Engineering
Urology
Wrongful Death